Together with the sex differences in pathology seen in mice transgenically expressing App with the Swedish mutation and presenilin 1 with the A246E mutation37, these data indicate the sex differences in AD-related genes are not limited to risk factors like APOE but pertinent to dominant AD mutations as well (for review, see38). This evidence concerns the gene PSEN1 and Alzheimer disease.